Li J R, Holets R J, Kottke B A
Atherosclerosis. 1980 Aug;36(4):559-65. doi: 10.1016/0021-9150(80)90248-8.
The effects of probucol treatment on cholesterol metabolism were examined in rats. Male Sprague-Dawley rats were divided into 3 groups: one group was given 0.25% probucol containing chow diet, one group was given 0.25% clofibrate containing chow diet, and the third group was fed chow diet alone. All groups of rats were maintained on these regimens for 4 weeks before killing. Probucol treatment resulted in a decrease in plasma cholesterol and cholesterol 7 alpha-hydroxylase activity. Clofibrate treatment resulted in a reduction of plasma cholesterol, hepatic HMG-CoA reductase and cholesterol 7 alpha-hydroxylase activities. The fecal excretion of neutral and acidic sterols were decreased significantly in the probucol or clofibrate-treated rats. In the bile there was a decrease in the concentration of total bile acids. These results suggest the mechanism for hypocholesterolemic action of probucol to be different from that of clofibrate.
在大鼠中研究了普罗布考治疗对胆固醇代谢的影响。雄性斯普拉格-道利大鼠被分为3组:一组给予含0.25%普罗布考的饲料,一组给予含0.25%氯贝丁酯的饲料,第三组仅喂普通饲料。所有组的大鼠在处死前按这些方案饲养4周。普罗布考治疗导致血浆胆固醇和胆固醇7α-羟化酶活性降低。氯贝丁酯治疗导致血浆胆固醇、肝HMG-CoA还原酶和胆固醇7α-羟化酶活性降低。在普罗布考或氯贝丁酯治疗的大鼠中,中性和酸性固醇的粪便排泄显著减少。胆汁中总胆汁酸的浓度降低。这些结果表明,普罗布考降胆固醇作用的机制与氯贝丁酯不同。